Singapore

The industry outperformed the output of the manufacturing sector, which fell 6.9%.

This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.

The city trails only behind China and India in terms of deal value.

$595m went to firms geared towards health management solutions.

There is little doubt that the Asia Pacific region represents a key growth ambition for the majority of Life Sciences companies. Statistics around unmet healthcare needs are well-known and, as the saying “necessity is the mother of innovation” goes to show, the Asia Pacific has an opportunity to leapfrog the West when it comes to novel therapies and approaches to market access. But at the same time, cost control and compliance remain sizeable challenges.

Only 15% of life sciences firms believe digital tools could enhance customer experience.

These three firms’ average dividend yield came at 3.3% over the same period.

Users can receive lifestyle tips and health recommendations based on individual DNA.

It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.

Operating revenue fell due to the promotion and building costs for its Chongqing hospital.

It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.

Increased government expenditure will support the segment.

Two in five health practitioners recommend a more integrated hospital-home care approach.

The upcoming facility is expected to start its operations in late 2020.

The push for domestic production will divert more funds into research and development to cushion against trade tensions.

India’s foreign investments into the sector crashed 60% in 2017 and 2018 down to $67m.